News

Out Now | Pharmalytics #3, the exclusive Pharma.Aero report on global markets & trends

The third edition of Pharmalyticsย  is now available exclusively to Pharma.Aero members. The quarterly report covers Q1 2025, offering powerful data, critical updates, actionable trends, and expert analysis on Life Sciences and MedTech supply chain and logistics.

These exclusive reports are designed for Pharma.Aero members only. To learn more and become a member visit our website here.

Here are 5 critical developments you won’t want to miss:

1๏ธโƒฃ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐“๐ซ๐š๐๐ž ๐š๐ง๐ ๐ญ๐ก๐ž ๐„๐ซ๐จ๐ฌ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ซ๐ž๐๐ข๐œ๐ญ๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ: ๐€ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐๐ž๐ซ๐ฌ๐ฉ๐ž๐œ๐ญ๐ข๐ฏ๐ž
In just a few weeks, U.S. trade policy swings have gone from sweeping tariffs to sector-specific threats to temporary reprieves โ€” shaking industry confidence. We explore how this volatility is reshaping global pharmaceutical supply chains.

2๏ธโƒฃ ๐…๐ซ๐จ๐ฆ ๐€๐ง๐ญ๐ข๐›๐ข๐จ๐ญ๐ข๐œ๐ฌ ๐ญ๐จ ๐‡๐จ๐ซ๐ฆ๐จ๐ง๐ž๐ฌ: ๐€ ๐ƒ๐ž๐ž๐ฉ ๐ƒ๐ข๐ฏ๐ž ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ž ๐„๐”โ€™๐ฌ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ ๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ๐ฌ
Recent shortages across Europe exposed the growing dependence on China for essential drug components. We break down where vulnerabilities lie and what it means for Europe’s pharmaceutical security.

3๏ธโƒฃ ๐Œ๐š๐ฉ๐ฉ๐ข๐ง๐  ๐†๐ฅ๐จ๐›๐š๐ฅ ๐•๐ž๐ญ๐ž๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐“๐ซ๐š๐๐ž: ๐Œ๐š๐ฃ๐จ๐ซ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ๐ž๐ซ๐ฌ, ๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ๐ž๐ซ๐ฌ, ๐š๐ง๐ ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ฌ
With veterinary pharmaceuticals growing faster than human pharma, we track how vaccine trade routes are evolving โ€” and whoโ€™s leading the charge.

4๏ธโƒฃ ๐๐ซ๐ž๐š๐ค๐ข๐ง๐  ๐ญ๐ก๐ž ๐‚๐จ๐ฅ๐ ๐‚๐ก๐š๐ข๐ง: ๐‡๐จ๐ฐ ๐“๐ก๐ž๐ซ๐ฆ๐จ๐ฌ๐ญ๐š๐›๐ฅ๐ž ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ ๐€๐ซ๐ž ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐’๐ญ๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐š๐ง๐ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐‹๐จ๐ ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ
Driven by post-pandemic disruptions and rising geopolitical instability, scientists are pioneering innovations that extend vaccine shelf life, boost product resilience, and reduce dependence on costly cold chain systems.

5๏ธโƒฃ ๐๐ก๐š๐ซ๐ฆ๐š & ๐‹๐ข๐Ÿ๐ž ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ ๐‹๐จ๐ ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ๐ฌ Q1 2025: Regional mergers, bold integrator moves, and a strategic redirection of supply chains away from geopolitical risk zones.

Pharmalytics is your go-to quarterly briefing โ€” giving Pharma.Aero members the intelligence they need to navigate uncertainty, anticipate risks, and seize new opportunities.

All Pharmalytics reports are uploaded for our members in the Member Area of our website.

Back to overview
My cart
Your cart is empty.

Looks like you haven't made a choice yet.

My cart
Your cart is empty.

Looks like you haven't made a choice yet.